We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant

Delisted

TROVW was delisted on the 30th of May, 2017.

4 hedge funds and large institutions have $1.45M invested in TrovaGene, Inc. Warrant in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 24 (+2)

39% less capital invested

Capital invested by funds: $2.39M → $1.45M (-$933K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$1.44K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.01K
2
TRCT
Tower Research Capital (TRC)
New York
-$304
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$1.45M -$5.01K -1,500 -0.3%
GSC
2
Ground Swell Capital
South Carolina
$1K +$1.3K +390 New
U
3
UBS
Switzerland
$1K +$1.44K +430 New
TRCT
4
Tower Research Capital (TRC)
New York
-$304 -91 -47%

TROVW Hedge Fund Activity: Q2 2014 in Review

4 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q2 2014, worth a combined $1.45M — down 39% from $2.39M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TROVW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was UBS, opening a new position worth an estimated $1.44K. The largest seller was Millennium Management, cutting an estimated $5.01K.

  • 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q2 2014, up from 2 in Q1 2014.
  • Funds reported $1.45M of TrovaGene, Inc. Warrant stock for Q2 2014, down 39% quarter-over-quarter.
  • 2 funds opened new TrovaGene, Inc. Warrant positions in Q2 2014 and 0 closed out, a net change of +2 holders.
  • The largest TrovaGene, Inc. Warrant buyer in Q2 2014 was UBS, an estimated $1.44K added.
  • The largest TrovaGene, Inc. Warrant seller in Q2 2014 was Millennium Management, an estimated $5.01K sold.

Based on aggregated 13F filings for Q2 2014.